A detailed history of Israel Englander (Millennium Management LLC) transactions in Nektar Therapeutics stock. As of the latest transaction made, Millennium Management LLC holds 5,061,719 shares of NKTR stock, worth $5.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,061,719
Previous 4,659,469 8.63%
Holding current value
$5.06 Million
Previous $5.78 Million 13.9%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.11 - $1.48 $446,497 - $595,330
402,250 Added 8.63%
5,061,719 $6.58 Million
Q2 2024

Aug 14, 2024

BUY
$0.9 - $1.83 $1.51 Million - $3.07 Million
1,674,924 Added 56.12%
4,659,469 $5.78 Million
Q1 2024

May 15, 2024

BUY
$0.49 - $0.96 $680,314 - $1.33 Million
1,388,396 Added 86.98%
2,984,545 $2.78 Million
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.57 $1.21 Million - $1.64 Million
-2,874,669 Reduced 64.3%
1,596,149 $893,000
Q2 2023

Aug 14, 2023

BUY
$0.53 - $1.03 $2.34 Million - $4.55 Million
4,414,571 Added 7848.54%
4,470,818 $2.59 Million
Q1 2023

May 15, 2023

SELL
$0.64 - $3.15 $356,263 - $1.75 Million
-556,662 Reduced 90.82%
56,247 $40,000
Q4 2022

Feb 14, 2023

BUY
$2.03 - $4.28 $922,630 - $1.95 Million
454,498 Added 286.91%
612,909 $1.39 Million
Q3 2022

Nov 14, 2022

BUY
$3.04 - $5.14 $481,569 - $814,232
158,411 New
158,411 $507,000
Q2 2022

Aug 15, 2022

SELL
$3.17 - $6.17 $5.88 Million - $11.4 Million
-1,854,623 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.16 - $13.72 $2.55 Million - $8.42 Million
613,920 Added 49.48%
1,854,623 $10 Million
Q4 2021

Feb 14, 2022

BUY
$10.83 - $18.41 $6.32 Million - $10.7 Million
583,750 Added 88.86%
1,240,703 $16.8 Million
Q3 2021

Nov 15, 2021

BUY
$13.07 - $18.84 $1.05 Million - $1.52 Million
80,564 Added 13.98%
656,953 $11.8 Million
Q2 2021

Aug 16, 2021

BUY
$16.52 - $20.4 $7.74 Million - $9.56 Million
468,486 Added 434.17%
576,389 $9.89 Million
Q1 2021

May 17, 2021

SELL
$16.56 - $25.46 $8.49 Million - $13.1 Million
-512,935 Reduced 82.62%
107,903 $2.16 Million
Q4 2020

Feb 16, 2021

BUY
$15.77 - $19.03 $8.03 Million - $9.69 Million
509,165 Added 455.94%
620,838 $10.6 Million
Q3 2020

Nov 16, 2020

BUY
$16.59 - $24.79 $301,622 - $450,706
18,181 Added 19.45%
111,673 $1.85 Million
Q2 2020

Aug 14, 2020

SELL
$16.86 - $23.44 $682,543 - $948,921
-40,483 Reduced 30.22%
93,492 $2.17 Million
Q1 2020

May 14, 2020

SELL
$14.47 - $27.96 $7.5 Million - $14.5 Million
-518,445 Reduced 79.46%
133,975 $2.39 Million
Q4 2019

Feb 14, 2020

SELL
$15.87 - $23.12 $5.36 Million - $7.81 Million
-337,678 Reduced 34.11%
652,420 $14.1 Million
Q3 2019

Nov 14, 2019

BUY
$16.91 - $36.27 $16.7 Million - $35.9 Million
990,098 New
990,098 $18 Million
Q4 2018

Feb 14, 2019

SELL
$30.43 - $56.65 $25.8 Million - $48.1 Million
-848,202 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$46.46 - $68.49 $28.8 Million - $42.5 Million
-620,391 Reduced 42.24%
848,202 $51.7 Million
Q2 2018

Aug 14, 2018

BUY
$46.25 - $104.45 $18.1 Million - $40.9 Million
391,765 Added 36.38%
1,468,593 $71.7 Million
Q1 2018

May 15, 2018

BUY
$57.4 - $108.44 $61.8 Million - $117 Million
1,076,828 New
1,076,828 $114 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $187M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.